Allegra CJ, Rumble RB, Schilsky RL (2016). Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical
Oncology Provisional Clinical Opinion Update 2015 Summary. Journal of Oncology Practice, 12(2), 180-181. doi:10.1200/jop.2015.007898.

Ambadapadi S, Munuswamy-Ramanujam G, Zheng D, Sullivan C, Dai E, Morshed S, McFadden B, Feldman E, Pinard M, McKenna R, Tibbetts S, Lucas A (2015). Reactive Center Loop (RCL) Peptides Derived from Serpins Display Independent Coagulation and Immune Modulating Activities. Journal of Biological Chemistry, 291(6), pp.2874-2887.

Alvarnas JC, Le Rademacher J, Wang Y, Little RF, Akpek G, Ayala E, Devine S, Baiocchi R, Lozanski G, Kaplan L, Noy A, Popat U, Hsu J, Morris LE Jr, Thompson J, Horowitz MM, Mendizabal A, Levine A, Krishnan A, Forman SJ, Navarro WH, Ambinder R (2016). Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial. Blood, 128(8), 1050-1058. doi:10.1182/blood-2015-08-664706.

Arcipowski KM, Bulic M, Gurbuxani S, Licht JD. Loss of Mll3 Catalytic Function Promotes Aberrant Myelopoiesis. PLoS ONE. 2016;11(9):e0162515. doi:10.1371/journal.pone.0162515.

Asselin BL, Devidas M, Chen L, Franco VI, Pullen J, Borowitz MJ, Hutchison RE, Ravindranath Y, Armenian SH, Camitta BM, Lipshultz SE (2016). Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children’s Oncology Group Randomized Trial Pediatric Oncology Group 9404. Journal of Clinical Oncology, 34(8), 854-862. doi:10.1200/jco.2015.60.8851.

Bagatell R, McHugh K, Naranjo A, Van Ryn C, Kirby C, Brock P, Lyons KA, States LJ, Rojas Y, Miller A, Volchenboum SL, Simon T, Krug B, Sarnacki S, Valteau-Couanet D, Schweinitz DV, Kammer B, Granata C, Pio L, Park JR, Nuchtern J. Assessment of Primary Site Response in Children With High-Risk Neuroblastoma: An International Multicenter Study. Journal of Clinical Oncology. 2016;34(7):740-746. doi:10.1200/JCO.2015.63.2042.

Dai L, Qiao J, Nguyen D, Struckhoff AP, Doyle L, Bonstaff K, Del Valle L, Parsons C, Toole BP, Renne R, Qin Z (2016). Role of heme oxygenase-1 in the pathogenesis and tumorigenicity of Kaposi’s sarcoma-associated herpesvirus. Oncotarget. doi:10.18632/oncotarget. 7227

Dizon DS, Krilov L, Cohen E, Gangadhar T, Ganz PA, Hensing TA, Hunger S, Krishnamurthi SS, Lassman AB, Markham MJ, Mayer E, Neuss M, Sumanta KP, Richardson LC, Schilsky R, Schwartz GK, Spriggs DR, Villalona-Calero MA, Villani G, Masters G (2016). Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. Journal of Clinical Oncology, 34(9), 987-1011. doi:10.1200/jco.2015.65.8427.

He Y, Wilkie DJ, Nazari J, Wang R, Messing RO, DeSimone J, Molokie RE, Wang ZJ (2016). PKCδ-targeted intervention relieves chronic pain in a murine sickle cell disease model. Journal of Clinical Investigation, 126(8), 3053-3057. doi: 10.1172/JCI86165.

Karol SE, Mattano LA Jr, Yang W, Maloney KW, Smith C, Liu C, Ramsey LB, Fernandez CA, Chang TY, Neale G, Cheng C, Mardis E, Fulton R, Scheet P, San Lucas FA, Larsen EC, Loh ML, Raetz EA, Hunger SP, Devidas M, Relling MV (2015). Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia. Blood, 127(5), 558-564. doi: 10.1182/blood-2015-10-673848.

Kim H-S, Nickoloff JA, Wu Y, Williamson EA, Sidhu GS, Reinert BL, Jaiswal AS, Srinivasan G, Patel B, Kong K, Burma S, Lee S-H, Hromas RA. Endonuclease EEPD1 Is a Gatekeeper for Repair of Stressed Replication Forks. The Journal of Biological Chemistry. 2017;292(7):2795-2804. doi:10.1074/jbc.M116.758235.

gomery SA, Ding S, Wilson JE, Brickey WJ, Mühlbauer M, McFadden RM, Hu P, Li Z, Jobin C, Lund PK, Ting J (2016). The Innate Immune Receptor NLRX1 Functions as a Tumor Suppressor by Reducing Colon Tumorigenesis and Key Tumor-Promoting Signals. Cell Reports, 14(11), pp.2562-2575.

Lagmay JP, Krailo MD, Dang H, Kim A, Hawkins DS, Beaty O, Widemann BC, Zwerdling T, Bomgaars L, Langevin AM, Grier HE, Weigel B, Blaney SM, Gorlick R, Janeway KA (2016). Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Childrens Cancer Group, Pediatric Oncology Group, and Childrens Oncology Group: Learning From the Past to Move Forward. Journal of Clinical Oncology, 34(25), 3031-3038. doi:10.1200/jco.2015.65.5381.

Lamba V, Jia B, Liang F, STAT5A and STAT5B have opposite correlations with drug response gene expression, Biochemical and Biophysical Research Communications, Volume 479, Issue 2, 2016, Pages 117-124, ISSN 0006-291X, http://dx.doi.org/10.1016/j.bbrc.2016.06.011.

Larsen EC, Devidas M, Chen S, Salzer WL, Raetz EA, Loh ML, Mattano LA Jr, Cole C, Eicher A, Haugan M, Sorenson M, Heerema NA, Carroll AA, Gastier-Foster JM, Borowitz MJ, Wood BL, Willman CL, Winick NJ, Hunger SP, Carroll WL (2016). Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group Study AALL0232. Journal of Clinical Oncology, 34(20), 2380-2388. doi:10.1200/jco.2015.62.4544.

Lee M-S, Yuan H, Jeon H, Zhu Y, Yoo S, Shi S, Krueger B, Renne R, Lu C, Jung JU, Gao, S-J (2016). Human Mesenchymal Stem Cells of Diverse Origins Support Persistent Infection with Kaposi’s Sarcoma-Associated Herpesvirus and Manifest Distinct Angiogenic, Invasive, and Transforming Phenotypes. mBio, 7(1), e02109–15. http://doi.org/10.1128/mBio.02109-15.

Ling C, Bhukhai K, Yin Z, Tan M, Yoder M, Leboulch P, Payen E, Srivastava A (2016). High-Efficiency Transduction of Primary Human Hematopoietic Stem/Progenitor Cells by AAV6 Vectors: Strategies for Overcoming Donor-Variation and Implications in Genome Editing. Scientific Reports, 6(1).

Liu C, Yang W, Devidas M, Cheng C, Pei D, Smith C, Carroll WL, Raetz EA, Bowman WP, Larsen EC, Maloney KW, Martin PL, Mattano LA Jr, Winick NJ, Mardis ER, Fulton RS, Bhojwani D, Howard SC, Jeha S, Pui CH, Hunger SP, Evans WE, Loh ML, Relling MV (2016). Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia. Journal of Clinical Oncology, 34(18), 2133-2140. doi:10.1200/jco.2015.64.5812.

Mousa, JJ, Yang Y, Tomkovich S, Shima A, Newsome, RC, Tripathi, P, Oswald E, Bruner SD, Jobin C (2016). MATE transport of the E. coli-derived genotoxin colibactin. Nature Microbiology. 1: 15009. doi:10.1038/nmicrobiol.2015.9.

Nichol JN, Dupéré-Richer D, Ezponda T, Licht JD, Miller WH. H3K27 Methylation: A Focal Point of Epigenetic Deregulation in Cancer. Advances in Cancer Research. 2016;131:59-95. doi:10.1016/bs.acr.2016.05.001.

Pope J, Tomkovich S, Yang Y, Jobin C (2017). Microbiota as a mediator of cancer progression and therapy. Translational Research, 179:139-154.

Shah MA, Renfro LA, Allegra CJ, André T, Gramont AD, Schmoll HJ, Haller DG, Alberts SR, Yothers G, Sargent DJ (2016). Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database. Journal of Clinical Oncology, 34(8), 843-853. doi:10.1200/jco.2015.63.0558.

Song N, Pogue-Geile KL, Gavin PG, Yothers G, Kim SR, Johnson NL, Lipchik C, Allegra CJ, Petrelli NJ, O’Connell MJ, Wolmark N, Paik S (2016). Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to
Intrinsic Subtypes. JAMA Oncology, 2(9), 1162. doi:10.1001/jamaoncol.2016.2314.

Teira P, Battiwalla M, Ramanathan M, Barrett AJ, Ahn KW, Chen M, Green JS, Saad A, Antin JH, Savani BN, Lazarus HM, Seftel M, Saber W, Marks D, Aljurf M, Norkin M, Wingard JR, Lindemans CA, Boeckh M, Riches ML, Auletta JJ (2016). Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis. Blood, 127(20), 2427-2438. doi:10.1182/blood-2015-11-679639.

Uddin M, Sultana D, Lorentsen K, Cho J, Kirst M, Brantly M, Califano D, Sant’Angelo D, Avram D (2016). Transcription factor Bcl11b sustains iNKT1 and iNKT2 cell programs, restricts iNKT17 cell program, and governs iNKT cell survival. Proceedings of the National Academy of Sciences, 113(27), pp.7608-7613.

Wang K, Amdur R, Mendenhall W, Green R, Aumer S, Hackman T, Zanation A, Zevallos J, Patel S, Weissler M, Chera, B (2016). Impact of post-chemoradiotherapy superselective/selective neck dissection on patient reported quality of life. Oral Oncology, 58, pp.21-26.

Wang Y, Li D, Luo J, Tian G, Zhao LY, Liao D (2016). Intrinsic cellular signaling mechanisms determine the sensitivity of cancer cells to virus-induced apoptosis. Scientific Reports. 2016;6:37213. doi:10.1038/srep37213.

Wingard JR (2016). A sniff to chase ill humors away. Blood, 128(7), 889-890. doi:10.1182/blood-2016-06-723932.

Yothers G, Song N, George, TJ (2016). Cancer Hallmark–Based Gene Sets and Personalized Medicine for Patients With Stage II Colon Cancer. JAMA Oncology, 2(1), 23. doi:10.1001/jamaoncol.2015.3614.

Zhang J, Feng H, Zhao J, Feldman E, Chen S, Yuan W, Huang C, Akbari O, Tibbetts S, Feng P (2016). IκB Kinase ε Is an NFATc1 Kinase that Inhibits T Cell Immune Response. Cell Reports, 16(2), pp.405-418.